nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—CYP2E1—Felbamate—epilepsy syndrome	0.114	0.176	CbGbCtD
Ethanolamine Oleate—CYP2E1—Trimethadione—epilepsy syndrome	0.114	0.176	CbGbCtD
Ethanolamine Oleate—CYP2E1—Clonazepam—epilepsy syndrome	0.0968	0.149	CbGbCtD
Ethanolamine Oleate—CYP2E1—Rufinamide—epilepsy syndrome	0.0789	0.122	CbGbCtD
Ethanolamine Oleate—CYP2E1—Propofol—epilepsy syndrome	0.0643	0.0993	CbGbCtD
Ethanolamine Oleate—CYP2E1—Phenobarbital—epilepsy syndrome	0.0615	0.0949	CbGbCtD
Ethanolamine Oleate—CYP2E1—Midazolam—epilepsy syndrome	0.0606	0.0935	CbGbCtD
Ethanolamine Oleate—CYP2E1—Diazepam—epilepsy syndrome	0.0583	0.0899	CbGbCtD
Ethanolamine Oleate—FABP5—tongue—epilepsy syndrome	0.0157	0.256	CbGeAlD
Ethanolamine Oleate—Pneumonia aspiration—Fosphenytoin—epilepsy syndrome	0.00923	0.057	CcSEcCtD
Ethanolamine Oleate—Pneumonia aspiration—Zonisamide—epilepsy syndrome	0.00839	0.0518	CcSEcCtD
Ethanolamine Oleate—Pneumonia aspiration—Phenytoin—epilepsy syndrome	0.00803	0.0496	CcSEcCtD
Ethanolamine Oleate—Oesophageal stenosis—Pregabalin—epilepsy syndrome	0.00751	0.0464	CcSEcCtD
Ethanolamine Oleate—FABP5—forebrain—epilepsy syndrome	0.00665	0.108	CbGeAlD
Ethanolamine Oleate—Pneumonia aspiration—Pregabalin—epilepsy syndrome	0.00532	0.0329	CcSEcCtD
Ethanolamine Oleate—Disseminated intravascular coagulation—Felbamate—epilepsy syndrome	0.00524	0.0324	CcSEcCtD
Ethanolamine Oleate—Pneumonia aspiration—Gabapentin—epilepsy syndrome	0.00488	0.0301	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Felbamate—epilepsy syndrome	0.00465	0.0287	CcSEcCtD
Ethanolamine Oleate—Disseminated intravascular coagulation—Lamotrigine—epilepsy syndrome	0.00453	0.028	CcSEcCtD
Ethanolamine Oleate—FABP5—spinal cord—epilepsy syndrome	0.00429	0.0698	CbGeAlD
Ethanolamine Oleate—FABP5—head—epilepsy syndrome	0.00381	0.0621	CbGeAlD
Ethanolamine Oleate—Necrosis—Phenobarbital—epilepsy syndrome	0.00372	0.023	CcSEcCtD
Ethanolamine Oleate—FABP5—nervous system—epilepsy syndrome	0.00361	0.0588	CbGeAlD
Ethanolamine Oleate—FABP4—head—epilepsy syndrome	0.00356	0.058	CbGeAlD
Ethanolamine Oleate—Alpha-Linolenic Acid—SLC8A1—epilepsy syndrome	0.00351	0.527	CrCbGaD
Ethanolamine Oleate—FABP5—central nervous system—epilepsy syndrome	0.00348	0.0566	CbGeAlD
Ethanolamine Oleate—FABP5—cerebellum—epilepsy syndrome	0.0034	0.0554	CbGeAlD
Ethanolamine Oleate—FABP4—nervous system—epilepsy syndrome	0.00338	0.055	CbGeAlD
Ethanolamine Oleate—F12—brain—epilepsy syndrome	0.00325	0.0529	CbGeAlD
Ethanolamine Oleate—Oesophageal ulcer—Pregabalin—epilepsy syndrome	0.00319	0.0197	CcSEcCtD
Ethanolamine Oleate—Varicose vein—Pregabalin—epilepsy syndrome	0.00312	0.0193	CcSEcCtD
Ethanolamine Oleate—F12—Blood Clotting Cascade—PLAU—epilepsy syndrome	0.00305	0.0265	CbGpPWpGaD
Ethanolamine Oleate—Retrosternal pain—Pregabalin—epilepsy syndrome	0.00289	0.0178	CcSEcCtD
Ethanolamine Oleate—Varicose vein—Gabapentin—epilepsy syndrome	0.00286	0.0177	CcSEcCtD
Ethanolamine Oleate—FABP5—brain—epilepsy syndrome	0.00276	0.045	CbGeAlD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—DUSP1—epilepsy syndrome	0.00259	0.0225	CbGpPWpGaD
Ethanolamine Oleate—FABP4—brain—epilepsy syndrome	0.00258	0.0421	CbGeAlD
Ethanolamine Oleate—Pleural effusion—Felbamate—epilepsy syndrome	0.00244	0.0151	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—JUND—epilepsy syndrome	0.00241	0.0209	CbGpPWpGaD
Ethanolamine Oleate—Necrosis—Felbamate—epilepsy syndrome	0.00238	0.0147	CcSEcCtD
Ethanolamine Oleate—FABP5—Pentobarbital—Amobarbital—epilepsy syndrome	0.00233	0.345	CbGdCrCtD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—PLAT—epilepsy syndrome	0.00227	0.0197	CbGpPWpGaD
Ethanolamine Oleate—Necrosis—Phenytoin—epilepsy syndrome	0.00223	0.0138	CcSEcCtD
Ethanolamine Oleate—Alpha-Linolenic Acid—TRPV1—epilepsy syndrome	0.00217	0.325	CrCbGaD
Ethanolamine Oleate—FABP5—Pentobarbital—Phenobarbital—epilepsy syndrome	0.00206	0.305	CbGdCrCtD
Ethanolamine Oleate—Abscess—Lamotrigine—epilepsy syndrome	0.00204	0.0126	CcSEcCtD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—PLAUR—epilepsy syndrome	0.00198	0.0172	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Vigabatrin—epilepsy syndrome	0.00179	0.0111	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Felbamate—epilepsy syndrome	0.00171	0.0106	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Valproic Acid—epilepsy syndrome	0.00168	0.0104	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Zonisamide—epilepsy syndrome	0.00167	0.0103	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—JUNB—epilepsy syndrome	0.00164	0.0143	CbGpPWpGaD
Ethanolamine Oleate—Necrosis—Valproic Acid—epilepsy syndrome	0.00164	0.0101	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—DOCK7—epilepsy syndrome	0.00163	0.0142	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TH—epilepsy syndrome	0.00163	0.0141	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Rufinamide—epilepsy syndrome	0.00161	0.00995	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Oxcarbazepine—epilepsy syndrome	0.00159	0.00985	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Pregabalin—epilepsy syndrome	0.00152	0.00937	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Lamotrigine—epilepsy syndrome	0.00148	0.00913	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Felbamate—epilepsy syndrome	0.00147	0.00909	CcSEcCtD
Ethanolamine Oleate—Abscess—Pregabalin—epilepsy syndrome	0.00147	0.00907	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Clobazam—epilepsy syndrome	0.00147	0.00907	CcSEcCtD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—PLAU—epilepsy syndrome	0.00139	0.012	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	0.00136	0.0118	CbGpPWpGaD
Ethanolamine Oleate—Abscess—Gabapentin—epilepsy syndrome	0.00135	0.00832	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—LAMP2—epilepsy syndrome	0.00133	0.0115	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN9A—epilepsy syndrome	0.00129	0.0112	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN8A—epilepsy syndrome	0.00129	0.0112	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN4A—epilepsy syndrome	0.00129	0.0112	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN3A—epilepsy syndrome	0.00129	0.0112	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Lamotrigine—epilepsy syndrome	0.00127	0.00786	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Pregabalin—epilepsy syndrome	0.00126	0.00779	CcSEcCtD
Ethanolamine Oleate—FABP5—Ethopropazine—Carbamazepine—epilepsy syndrome	0.00121	0.179	CbGdCrCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—NR3C1—epilepsy syndrome	0.00117	0.0102	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation increased—Gabapentin—epilepsy syndrome	0.00116	0.00714	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00116	0.01	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00116	0.01	CbGpPWpGaD
Ethanolamine Oleate—FABP5—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00115	0.171	CbGdCrCtD
Ethanolamine Oleate—Pneumonia—Fosphenytoin—epilepsy syndrome	0.00113	0.007	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Vigabatrin—epilepsy syndrome	0.00111	0.00683	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—SLC8A2—epilepsy syndrome	0.0011	0.00956	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Amobarbital—epilepsy syndrome	0.0011	0.00677	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Diazepam—epilepsy syndrome	0.00109	0.00672	CcSEcCtD
Ethanolamine Oleate—FABP4—Lipid and lipoprotein metabolism—ALB—epilepsy syndrome	0.00107	0.00928	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—AGT—epilepsy syndrome	0.00106	0.00924	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Pregabalin—epilepsy syndrome	0.00106	0.00656	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—PLAU—epilepsy syndrome	0.00106	0.00918	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Felbamate—epilepsy syndrome	0.00105	0.0065	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—SLC8A3—epilepsy syndrome	0.00105	0.00912	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—KCNQ2—epilepsy syndrome	0.00103	0.00898	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—KCNQ3—epilepsy syndrome	0.00103	0.00898	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Zonisamide—epilepsy syndrome	0.00103	0.00637	CcSEcCtD
Ethanolamine Oleate—Chest pain—Lacosamide—epilepsy syndrome	0.001	0.00618	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Clonazepam—epilepsy syndrome	0.000993	0.00614	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Phenytoin—epilepsy syndrome	0.000987	0.00609	CcSEcCtD
Ethanolamine Oleate—CYP2E1—CYP2E1 reactions—CYP2C19—epilepsy syndrome	0.000986	0.00857	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Oxcarbazepine—epilepsy syndrome	0.000981	0.00606	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—CACNB4—epilepsy syndrome	0.000981	0.00852	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN1B—epilepsy syndrome	0.000981	0.00852	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN1A—epilepsy syndrome	0.000981	0.00852	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Gabapentin—epilepsy syndrome	0.000974	0.00601	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Topiramate—epilepsy syndrome	0.000973	0.00601	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—WARS—epilepsy syndrome	0.000952	0.00827	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Carbamazepine—epilepsy syndrome	0.000942	0.00582	CcSEcCtD
Ethanolamine Oleate—CYP2E1—telencephalon—epilepsy syndrome	0.000937	0.0153	CbGeAlD
Ethanolamine Oleate—Renal failure acute—Pregabalin—epilepsy syndrome	0.000914	0.00564	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Lamotrigine—epilepsy syndrome	0.00091	0.00562	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—FOS—epilepsy syndrome	0.000897	0.00779	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CACNA1H—epilepsy syndrome	0.000897	0.00779	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—DCX—epilepsy syndrome	0.000897	0.00779	CbGpPWpGaD
Ethanolamine Oleate—Pain—Phenobarbital—epilepsy syndrome	0.00089	0.0055	CcSEcCtD
Ethanolamine Oleate—CYP2E1—CYP2E1 reactions—CYP2D6—epilepsy syndrome	0.000885	0.00768	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CCL2—epilepsy syndrome	0.000876	0.00761	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000876	0.00761	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Gabapentin—epilepsy syndrome	0.000838	0.00518	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—SCN2A—epilepsy syndrome	0.000834	0.00724	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CACNA1G—epilepsy syndrome	0.000834	0.00724	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.00083	0.00513	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Phenobarbital—epilepsy syndrome	0.000823	0.00508	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Topiramate—epilepsy syndrome	0.000819	0.00506	CcSEcCtD
Ethanolamine Oleate—Chest pain—Propofol—epilepsy syndrome	0.000804	0.00497	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000801	0.00696	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Levetiracetam—epilepsy syndrome	0.000777	0.0048	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000771	0.0067	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Propofol—epilepsy syndrome	0.000771	0.00476	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Lacosamide—epilepsy syndrome	0.000758	0.00469	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000754	0.00466	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Clobazam—epilepsy syndrome	0.000736	0.00455	CcSEcCtD
Ethanolamine Oleate—CYP2E1—medulla oblongata—epilepsy syndrome	0.000736	0.012	CbGeAlD
Ethanolamine Oleate—Chest pain—Vigabatrin—epilepsy syndrome	0.000731	0.00451	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Valproic Acid—epilepsy syndrome	0.000723	0.00447	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000719	0.00444	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—TEK—epilepsy syndrome	0.000709	0.00616	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CNTN2—epilepsy syndrome	0.000709	0.00616	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.0007	0.00608	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Felbamate—epilepsy syndrome	0.000696	0.0043	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Diazepam—epilepsy syndrome	0.00069	0.00426	CcSEcCtD
Ethanolamine Oleate—Chest pain—Zonisamide—epilepsy syndrome	0.000682	0.00421	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—RELA—epilepsy syndrome	0.000681	0.00592	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—ANK3—epilepsy syndrome	0.00068	0.0059	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SLIT2—epilepsy syndrome	0.00068	0.0059	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CA13—epilepsy syndrome	0.000679	0.0059	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000668	0.00412	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—FLNA—epilepsy syndrome	0.000667	0.00579	CbGpPWpGaD
Ethanolamine Oleate—Pain—Propofol—epilepsy syndrome	0.000659	0.00407	CcSEcCtD
Ethanolamine Oleate—Chest pain—Clonazepam—epilepsy syndrome	0.000657	0.00406	CcSEcCtD
Ethanolamine Oleate—CYP2E1—spinal cord—epilepsy syndrome	0.000656	0.0107	CbGeAlD
Ethanolamine Oleate—Body temperature increased—Acetazolamide—epilepsy syndrome	0.000656	0.00405	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000656	0.00569	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CACNA1D—epilepsy syndrome	0.000654	0.00568	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Pregabalin—epilepsy syndrome	0.000654	0.00404	CcSEcCtD
Ethanolamine Oleate—Chest pain—Phenytoin—epilepsy syndrome	0.000653	0.00403	CcSEcCtD
Ethanolamine Oleate—Chest pain—Oxcarbazepine—epilepsy syndrome	0.000649	0.00401	CcSEcCtD
Ethanolamine Oleate—Pain—Midazolam—epilepsy syndrome	0.000645	0.00398	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—JUN—epilepsy syndrome	0.000644	0.00559	CbGpPWpGaD
Ethanolamine Oleate—Pain—Levetiracetam—epilepsy syndrome	0.000637	0.00393	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—KCNMA1—epilepsy syndrome	0.000632	0.00549	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—GDNF—epilepsy syndrome	0.000632	0.00549	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00063	0.00389	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—MMP9—epilepsy syndrome	0.000627	0.00544	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000626	0.00386	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—SLC8A1—epilepsy syndrome	0.000625	0.00542	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Carbamazepine—epilepsy syndrome	0.000623	0.00385	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000622	0.00384	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—SPTAN1—epilepsy syndrome	0.000612	0.00532	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Xenobiotics—CYP2C19—epilepsy syndrome	0.000611	0.00531	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Propofol—epilepsy syndrome	0.000609	0.00376	CcSEcCtD
Ethanolamine Oleate—Chest pain—Lamotrigine—epilepsy syndrome	0.000602	0.00372	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Gabapentin—epilepsy syndrome	0.0006	0.0037	CcSEcCtD
Ethanolamine Oleate—Pain—Vigabatrin—epilepsy syndrome	0.000599	0.0037	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000597	0.00369	CcSEcCtD
Ethanolamine Oleate—Pain—Diazepam—epilepsy syndrome	0.00059	0.00364	CcSEcCtD
Ethanolamine Oleate—Sodium lauryl sulfate—ALB—epilepsy syndrome	0.000589	0.0885	CrCbGaD
Ethanolamine Oleate—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000589	0.00364	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000588	0.00511	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—head—epilepsy syndrome	0.000583	0.0095	CbGeAlD
Ethanolamine Oleate—Pain—Felbamate—epilepsy syndrome	0.000571	0.00353	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000568	0.00351	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000554	0.00342	CcSEcCtD
Ethanolamine Oleate—CYP2E1—nervous system—epilepsy syndrome	0.000553	0.00901	CbGeAlD
Ethanolamine Oleate—CYP2E1—Xenobiotics—CYP2D6—epilepsy syndrome	0.000548	0.00476	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000547	0.00475	CbGpPWpGaD
Ethanolamine Oleate—Pain—Clonazepam—epilepsy syndrome	0.000539	0.00333	CcSEcCtD
Ethanolamine Oleate—CYP2E1—central nervous system—epilepsy syndrome	0.000532	0.00867	CbGeAlD
Ethanolamine Oleate—Pain—Oxcarbazepine—epilepsy syndrome	0.000532	0.00329	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Felbamate—epilepsy syndrome	0.000528	0.00326	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000527	0.00458	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PPIA—epilepsy syndrome	0.000525	0.00456	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—cerebellum—epilepsy syndrome	0.00052	0.00848	CbGeAlD
Ethanolamine Oleate—Body temperature increased—Zonisamide—epilepsy syndrome	0.000517	0.00319	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—GLUD1—epilepsy syndrome	0.000515	0.00447	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CERS1—epilepsy syndrome	0.000515	0.00447	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—L2HGDH—epilepsy syndrome	0.000515	0.00447	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ADK—epilepsy syndrome	0.000515	0.00447	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—FAR1—epilepsy syndrome	0.000515	0.00447	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PDXK—epilepsy syndrome	0.000515	0.00447	CbGpPWpGaD
Ethanolamine Oleate—Pain—Carbamazepine—epilepsy syndrome	0.000511	0.00315	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—TCF4—epilepsy syndrome	0.000505	0.00439	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Topiramate—epilepsy syndrome	0.000504	0.00312	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Clonazepam—epilepsy syndrome	0.000498	0.00308	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Phenytoin—epilepsy syndrome	0.000495	0.00305	CcSEcCtD
Ethanolamine Oleate—Pain—Lamotrigine—epilepsy syndrome	0.000494	0.00305	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000492	0.00304	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000483	0.00419	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—ATP2A2—epilepsy syndrome	0.000479	0.00416	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—PRNP—epilepsy syndrome	0.000479	0.00416	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Valproic Acid—epilepsy syndrome	0.000478	0.00296	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000472	0.00292	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—EPM2A—epilepsy syndrome	0.000471	0.00409	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NHLRC1—epilepsy syndrome	0.000471	0.00409	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GAMT—epilepsy syndrome	0.000471	0.00409	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PNPO—epilepsy syndrome	0.000471	0.00409	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—ITGA2—epilepsy syndrome	0.000465	0.00404	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000459	0.00283	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000456	0.00282	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—CDH2—epilepsy syndrome	0.00045	0.00391	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—TNF—epilepsy syndrome	0.000447	0.00388	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000443	0.00385	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—QDPR—epilepsy syndrome	0.000438	0.0038	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CA4—epilepsy syndrome	0.000438	0.0038	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Pregabalin—epilepsy syndrome	0.000433	0.00267	CcSEcCtD
Ethanolamine Oleate—CYP2E1—brain—epilepsy syndrome	0.000423	0.00689	CbGeAlD
Ethanolamine Oleate—FABP4—Developmental Biology—ACTB—epilepsy syndrome	0.000422	0.00366	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000415	0.00256	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—ITGA2—epilepsy syndrome	0.000414	0.0036	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—COX3—epilepsy syndrome	0.000412	0.00357	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—ADRA2A—epilepsy syndrome	0.000409	0.00355	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PLAT—epilepsy syndrome	0.000407	0.00354	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Gabapentin—epilepsy syndrome	0.000397	0.00245	CcSEcCtD
Ethanolamine Oleate—Dihomo-gamma-linolenic acid—PTGS2—epilepsy syndrome	0.000396	0.0595	CrCbGaD
Ethanolamine Oleate—Pain—Valproic Acid—epilepsy syndrome	0.000392	0.00242	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—PFKL—epilepsy syndrome	0.00039	0.00339	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—KCNB1—epilepsy syndrome	0.00039	0.00339	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLCO1A2—epilepsy syndrome	0.00039	0.00339	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CACNA2D2—epilepsy syndrome	0.00039	0.00339	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC6A8—epilepsy syndrome	0.00039	0.00339	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—NOS1—epilepsy syndrome	0.000383	0.00333	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.000381	0.00331	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.00038	0.00235	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000379	0.00329	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000363	0.00224	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—AKT3—epilepsy syndrome	0.000359	0.00311	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—UPB1—epilepsy syndrome	0.000357	0.0031	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NEU1—epilepsy syndrome	0.000357	0.0031	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ATIC—epilepsy syndrome	0.000357	0.0031	CbGpPWpGaD
Ethanolamine Oleate—Pain—Pregabalin—epilepsy syndrome	0.000355	0.00219	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—PLAUR—epilepsy syndrome	0.000354	0.00308	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—DLG4—epilepsy syndrome	0.000354	0.00308	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—GRIN2B—epilepsy syndrome	0.000346	0.00301	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HSD17B4—epilepsy syndrome	0.000343	0.00298	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Topiramate—epilepsy syndrome	0.000334	0.00206	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—PPP1R3C—epilepsy syndrome	0.000332	0.00288	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GBE1—epilepsy syndrome	0.000332	0.00288	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Pregabalin—epilepsy syndrome	0.000328	0.00202	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—CDC42—epilepsy syndrome	0.000327	0.00284	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000327	0.00284	CbGpPWpGaD
Ethanolamine Oleate—Pain—Gabapentin—epilepsy syndrome	0.000325	0.00201	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000324	0.00282	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT3—epilepsy syndrome	0.00032	0.00278	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—ADAM10—epilepsy syndrome	0.000312	0.00271	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ASAH1—epilepsy syndrome	0.000312	0.00271	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—STXBP1—epilepsy syndrome	0.000303	0.00263	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Gabapentin—epilepsy syndrome	0.000301	0.00186	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—NT5E—epilepsy syndrome	0.000296	0.00257	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ALAD—epilepsy syndrome	0.000296	0.00257	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CDC42—epilepsy syndrome	0.000292	0.00253	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—FYN—epilepsy syndrome	0.000291	0.00253	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CACNA1A—epilepsy syndrome	0.000282	0.00245	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ALDH7A1—epilepsy syndrome	0.000282	0.00245	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—YWHAZ—epilepsy syndrome	0.00028	0.00243	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ST3GAL3—epilepsy syndrome	0.000276	0.0024	CbGpPWpGaD
Ethanolamine Oleate—Pain—Topiramate—epilepsy syndrome	0.000274	0.00169	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—ADSL—epilepsy syndrome	0.00027	0.00235	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—HES1—epilepsy syndrome	0.000267	0.00232	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GLUL—epilepsy syndrome	0.000265	0.0023	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CACNA1D—epilepsy syndrome	0.00026	0.00226	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—FYN—epilepsy syndrome	0.00026	0.00225	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MEF2C—epilepsy syndrome	0.000258	0.00224	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000256	0.00222	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000256	0.00222	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000254	0.0022	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Topiramate—epilepsy syndrome	0.000253	0.00156	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000252	0.00219	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000251	0.00218	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000249	0.00216	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PLAU—epilepsy syndrome	0.000249	0.00216	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TXNRD1—epilepsy syndrome	0.000243	0.00211	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AQP1—epilepsy syndrome	0.000236	0.00205	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PRKCB—epilepsy syndrome	0.000231	0.00201	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—NOS2—epilepsy syndrome	0.000228	0.00198	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000228	0.00198	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000227	0.00197	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000225	0.00195	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—KDR—epilepsy syndrome	0.000214	0.00186	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—KCNJ11—epilepsy syndrome	0.000214	0.00186	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CHRM3—epilepsy syndrome	0.000214	0.00186	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—CAT—epilepsy syndrome	0.000207	0.0018	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000206	0.00179	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—IL6ST—epilepsy syndrome	0.000205	0.00178	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000205	0.00178	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000199	0.00173	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000195	0.00169	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—ALB—epilepsy syndrome	0.000192	0.00167	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.000185	0.0016	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ABCG2—epilepsy syndrome	0.000174	0.00151	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP2C19—epilepsy syndrome	0.00017	0.00147	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP11A1—epilepsy syndrome	0.000169	0.00147	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000168	0.00145	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—FGF2—epilepsy syndrome	0.000166	0.00144	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—RELA—epilepsy syndrome	0.000154	0.00134	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000153	0.00133	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP2D6—epilepsy syndrome	0.000152	0.00132	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ADRA2A—epilepsy syndrome	0.000145	0.00126	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—BCHE—epilepsy syndrome	0.000144	0.00125	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC2A1—epilepsy syndrome	0.000138	0.0012	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PLCB1—epilepsy syndrome	0.000136	0.00118	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—SRC—epilepsy syndrome	0.000136	0.00118	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TH—epilepsy syndrome	0.000136	0.00118	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000134	0.00116	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—VEGFA—epilepsy syndrome	0.000132	0.00115	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MMP9—epilepsy syndrome	0.000131	0.00114	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SRC—epilepsy syndrome	0.000121	0.00105	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—VEGFA—epilepsy syndrome	0.000118	0.00102	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HMOX1—epilepsy syndrome	0.000113	0.000984	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CAT—epilepsy syndrome	0.000112	0.000971	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000112	0.000969	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP2C19—epilepsy syndrome	0.000109	0.000949	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ABCB1—epilepsy syndrome	0.000109	0.000944	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP11A1—epilepsy syndrome	0.000109	0.000943	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000108	0.000936	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000107	0.000931	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GPX1—epilepsy syndrome	0.000101	0.000878	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—TNF—epilepsy syndrome	0.000101	0.000877	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP2D6—epilepsy syndrome	9.81e-05	0.000852	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	9.67e-05	0.00084	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	9.04e-05	0.000785	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AGT—epilepsy syndrome	8.86e-05	0.00077	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—APOE—epilepsy syndrome	8.69e-05	0.000754	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—AKT1—epilepsy syndrome	8.44e-05	0.000733	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT1—epilepsy syndrome	7.52e-05	0.000653	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CA13—epilepsy syndrome	7.48e-05	0.000649	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—POMC—epilepsy syndrome	7.46e-05	0.000648	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ALB—epilepsy syndrome	6.8e-05	0.000591	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTGS2—epilepsy syndrome	5.95e-05	0.000517	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GLUD1—epilepsy syndrome	5.67e-05	0.000492	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—L2HGDH—epilepsy syndrome	5.67e-05	0.000492	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ADK—epilepsy syndrome	5.67e-05	0.000492	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—FAR1—epilepsy syndrome	5.67e-05	0.000492	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PDXK—epilepsy syndrome	5.67e-05	0.000492	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CERS1—epilepsy syndrome	5.67e-05	0.000492	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GAMT—epilepsy syndrome	5.18e-05	0.00045	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NHLRC1—epilepsy syndrome	5.18e-05	0.00045	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—EPM2A—epilepsy syndrome	5.18e-05	0.00045	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PNPO—epilepsy syndrome	5.18e-05	0.00045	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CA4—epilepsy syndrome	4.82e-05	0.000418	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—QDPR—epilepsy syndrome	4.82e-05	0.000418	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—POMC—epilepsy syndrome	4.8e-05	0.000417	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—COX3—epilepsy syndrome	4.53e-05	0.000393	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC6A8—epilepsy syndrome	4.3e-05	0.000373	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CACNA2D2—epilepsy syndrome	4.3e-05	0.000373	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PFKL—epilepsy syndrome	4.3e-05	0.000373	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLCO1A2—epilepsy syndrome	4.3e-05	0.000373	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—KCNB1—epilepsy syndrome	4.3e-05	0.000373	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NEU1—epilepsy syndrome	3.93e-05	0.000341	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—UPB1—epilepsy syndrome	3.93e-05	0.000341	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ATIC—epilepsy syndrome	3.93e-05	0.000341	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HSD17B4—epilepsy syndrome	3.78e-05	0.000328	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPP1R3C—epilepsy syndrome	3.65e-05	0.000317	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GBE1—epilepsy syndrome	3.65e-05	0.000317	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ASAH1—epilepsy syndrome	3.43e-05	0.000298	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—STXBP1—epilepsy syndrome	3.34e-05	0.00029	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NT5E—epilepsy syndrome	3.26e-05	0.000283	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALAD—epilepsy syndrome	3.26e-05	0.000283	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	3.11e-05	0.00027	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	3.11e-05	0.00027	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	3.04e-05	0.000264	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKT1—epilepsy syndrome	2.99e-05	0.00026	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ADSL—epilepsy syndrome	2.98e-05	0.000259	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GLUL—epilepsy syndrome	2.92e-05	0.000254	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	2.87e-05	0.000249	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	2.68e-05	0.000233	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AQP1—epilepsy syndrome	2.6e-05	0.000226	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	2.35e-05	0.000204	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	2.35e-05	0.000204	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	1.92e-05	0.000167	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	1.87e-05	0.000162	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	1.86e-05	0.000161	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	1.68e-05	0.000146	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	1.6e-05	0.000139	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—BCHE—epilepsy syndrome	1.59e-05	0.000138	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	1.52e-05	0.000132	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	1.5e-05	0.00013	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TH—epilepsy syndrome	1.49e-05	0.00013	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.25e-05	0.000108	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.23e-05	0.000107	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.2e-05	0.000104	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.11e-05	9.67e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AGT—epilepsy syndrome	9.76e-06	8.48e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—APOE—epilepsy syndrome	9.56e-06	8.3e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—POMC—epilepsy syndrome	8.22e-06	7.13e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALB—epilepsy syndrome	7.49e-06	6.5e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	6.55e-06	5.69e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKT1—epilepsy syndrome	3.29e-06	2.86e-05	CbGpPWpGaD
